Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03136055
Brief Title: Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas

First Submitted : April 18, 2017
First Submitted that Met QC Criteria : April 26, 2017
First Posted : May 2, 2017

Last Update Submitted that Met QC Criteria : October 8, 2020
Last Update Posted : October 9, 2020